Atrial Fibrillation: Considerations for the Use of BTK Inhibitors

In this article, we describe the considerations for the use of BTK inhibitors in lymphoid malignancies from the perspective of an oncology pharmacist.

http://www.cancernetwork.com/atrial-fibrillation-BTK

Source: CancerNetwork - November 15, 2018 Category: Cancer & Oncology Authors: Kelly Valla, PharmD, BCOP Source Type: news

More News: Atrial Fibrillation | Cancer & Oncology